Synopsis
0
CEP/COS
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Solubilizers
Emulsifying Agents
Thickeners and Stabilizers
Parenteral
Surfactant & Foaming Agents
Rheology Modifiers
Granulation
Controlled & Modified Release
Direct Compression
Lubricants & Glidants
Fillers, Diluents & Binders
Coating Systems & Additives
API Stability Enhancers
Film Formers & Plasticizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
27
PharmaCompass offers a list of Imiquimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imiquimod manufacturer or Imiquimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imiquimod manufacturer or Imiquimod supplier.
PharmaCompass also assists you with knowing the Imiquimod API Price utilized in the formulation of products. Imiquimod API Price is not always fixed or binding as the Imiquimod Price is obtained through a variety of data sources. The Imiquimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imiquimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imiquimod, including repackagers and relabelers. The FDA regulates Imiquimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imiquimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imiquimod manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imiquimod supplier is an individual or a company that provides Imiquimod active pharmaceutical ingredient (API) or Imiquimod finished formulations upon request. The Imiquimod suppliers may include Imiquimod API manufacturers, exporters, distributors and traders.
click here to find a list of Imiquimod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imiquimod DMF (Drug Master File) is a document detailing the whole manufacturing process of Imiquimod active pharmaceutical ingredient (API) in detail. Different forms of Imiquimod DMFs exist exist since differing nations have different regulations, such as Imiquimod USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Imiquimod DMF submitted to regulatory agencies in the US is known as a USDMF. Imiquimod USDMF includes data on Imiquimod's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Imiquimod USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Imiquimod suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Imiquimod Drug Master File in Korea (Imiquimod KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Imiquimod. The MFDS reviews the Imiquimod KDMF as part of the drug registration process and uses the information provided in the Imiquimod KDMF to evaluate the safety and efficacy of the drug.
After submitting a Imiquimod KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Imiquimod API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Imiquimod suppliers with KDMF on PharmaCompass.
A Imiquimod written confirmation (Imiquimod WC) is an official document issued by a regulatory agency to a Imiquimod manufacturer, verifying that the manufacturing facility of a Imiquimod active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Imiquimod APIs or Imiquimod finished pharmaceutical products to another nation, regulatory agencies frequently require a Imiquimod WC (written confirmation) as part of the regulatory process.
click here to find a list of Imiquimod suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imiquimod as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imiquimod API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imiquimod as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imiquimod and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imiquimod NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imiquimod suppliers with NDC on PharmaCompass.
Imiquimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imiquimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imiquimod GMP manufacturer or Imiquimod GMP API supplier for your needs.
A Imiquimod CoA (Certificate of Analysis) is a formal document that attests to Imiquimod's compliance with Imiquimod specifications and serves as a tool for batch-level quality control.
Imiquimod CoA mostly includes findings from lab analyses of a specific batch. For each Imiquimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imiquimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Imiquimod EP), Imiquimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imiquimod USP).
